Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2013; 19(18): 2793-2798
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2793
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2793
Patients | 150 |
Gender | |
Male | 100 |
Female | 50 |
Patients with histological assessment[20] | 103 |
Mild hepatitis (G0-G4) | 52 |
Moderate hepatitis (G5-G9) | 44 |
Severe hepatitis (G10-G18) | 5 |
Staging S0-S1 | 44 |
Staging S2 | 25 |
Staging S3 | 10 |
Staging S4-S5 | 9 |
Cirrhosis S6 | 2 |
Genotype | |
1a | 14 |
1b | 75 |
2 | 54 |
3 | 5 |
4 | 2 |
Comorbidity | |
Cardiovascular diseases | 13 |
Thyroid diseases | 7 |
Crohn’s disease | 1 |
GERD | 2 |
Diabetes mellitus type 2 | 2 |
HBV co-infection | 2 |
- Citation: Morisco F, Granata R, Stroffolini T, Guarino M, Donnarumma L, Gaeta L, Loperto I, Gentile I, Auriemma F, Caporaso N. Sustained virological response: A milestone in the treatment of chronic hepatitis C. World J Gastroenterol 2013; 19(18): 2793-2798
- URL: https://www.wjgnet.com/1007-9327/full/v19/i18/2793.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i18.2793